The RECHARGE Low Carbohydrate Diet Trial for Metastatic Cancer (RECHARGE)
Primary Purpose
Cancer, Breast Cancer, Colon Cancer
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Very low carbohydrate diet (approximately 20 grams per day)
Sponsored by
About this trial
This is an interventional treatment trial for Cancer focused on measuring Diet, Cancer, Alternative, Breast, Colon, Cervix, Uterus, Ovary, Metastatic, Nutrition, Carbohydrate
Eligibility Criteria
Inclusion Criteria:
- You're an adult with metastatic cancer (breast, colon; others may qualify) that has been resistant to chemotherapy or would like a break from chemotherapy.
- Your tumor shows up on a PET or PET/CT scan.
- You are willing to closely follow a diet which strictly limits your carbohydrate intake (sugars, starches, etc). We will help you with nutrition counseling but you must prepare your meals, or have someone help you prepare your meals.
- You are able to come to the Albert Einstein College of Medicine in Bronx, NY for an initial evaluation appointment and weekly nutrition counseling appointments for a four-week period.
Exclusion Criteria:
- Have a heart condition, liver condition or any other disease or condition that makes it difficult or medically hazardous (as determined by your doctor) for you to follow the study diet.
- Have kidney or kidney stone disease.
- Are too thin or have lost too much weight.
Sites / Locations
- The Albert Einstein College of Medicine of Yeshiva University
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Dietary modification
Arm Description
Patients are placed on a low carbohydrate diet (<30 grams/day) for 28 days.
Outcomes
Primary Outcome Measures
Change in tumor FDG uptake from PET/CT imaging over a 28 period. PET is done at baseline and 28 days
Secondary Outcome Measures
Safety of a very low carbohydrate diet in individuals with metastatic cancer
Full Information
NCT ID
NCT00444054
First Posted
March 5, 2007
Last Updated
October 29, 2020
Sponsor
Albert Einstein College of Medicine
Collaborators
Robert C. Atkins Foundation, Montefiore Medical Center
1. Study Identification
Unique Protocol Identification Number
NCT00444054
Brief Title
The RECHARGE Low Carbohydrate Diet Trial for Metastatic Cancer
Acronym
RECHARGE
Official Title
Pilot Feasibility Study Of A Low Carbohydrate Diet In Patients With Advanced Cancer
Study Type
Interventional
2. Study Status
Record Verification Date
October 2020
Overall Recruitment Status
Completed
Study Start Date
February 2006 (undefined)
Primary Completion Date
May 2010 (Actual)
Study Completion Date
May 2012 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Albert Einstein College of Medicine
Collaborators
Robert C. Atkins Foundation, Montefiore Medical Center
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
This study is for people whose cancer:
has resisted chemotherapy
are taking a break from chemotherapy
or are looking for an alternative to the toxic effects of chemotherapy
The trial is looking to see if a very low carbohydrate diet can inhibit the growth of certain cancers.
The two major goals of the RECHARGE study are to determine:
whether a very low carbohydrate diet can help participants reduce the amount of cancer in their bodies (as measured by a PET scan at the beginning and end of the study)
whether participants can feel well while maintaining their weight on a very low carbohydrate diet
This research study is for people with advanced cancers who decline chemotherapy or want to take a break from chemotherapy and have cancers that primarily feed on blood sugar. Examples of such cancers include metastatic breast cancer, colon cancer, cervical and uterine cancers, ovarian cancers, and many others.
The investigators' intervention consists of a 28-day diet of high protein foods such as fish, poultry, meats, eggs and cheese as well as plenty of vegetables. Participants may eat as much of the high protein foods as they wish and can eat up to two cups of vegetables per day.
Participants strictly eliminate carbohydrate-containing foods. These foods include all starches and sweets (breads, pasta, rice, potatoes, cereals, fruit, cakes, candies, soda with sugar, etc.).
Detailed Description
You may be eligible to participate in this one month research study if you are:
An adult with metastatic cancer (especially breast, colon, cervical, endometrial, ovarian; others may qualify) that has resisted prior attempts to treat it with courses of chemotherapy; or if you decline chemotherapy or are looking for a break, or you seek an alternative to medicines or therapies due to toxic effects.
Your tumor has shown up on a PET scan.
Willing to closely follow a diet and strictly limit your carbohydrate intake.
You will not be eligible to participate if you:
Have heart or liver condition or any other disease or condition that makes it difficult or medically hazardous (determined by your doctor) for you to follow the diet recommended for this study.
Have kidney or kidney stone disease.
Procedures:
We will obtain a PET/CT scan to determine your eligibility if you are otherwise interested in this protocol.
We will also obtain a second PET/CT scan at the end of the dietary trial (28 days).
We will also obtain blood and urine tests at weekly intervals during the trial.
Visits and contacts:
We will see you once/week for four weeks on the Albert Einstein, or Montefiore Medical Center Campus (your choice) for a total of 5 visits, and will call you on the phone at least one additional time each week. The first visit will take approximately one hour or as long as is needed to understand the diet correctly. The remaining visits will take approximately one-half hour. The PET/CT scan will take approximately 25 minutes in the camera. Waiting time varies for the procedure but is usually less than 20 minutes.
Compensation:
Low carbohydrate supplement shakes will be given to all participants.
All procedures and visits are without cost to the subject.
There are no funds for direct compensation.
Description of the Intervention:
The diet will severely restrict carbohydrates (that is, NO sugars or starches; no bread, pasta, rice, sugary drinks, potatoes or potato chips, cake, cookies, ice cream, etc).
You will be allowed to eat AS MUCH AS YOU LIKE of foods that have very small amounts of carbohydrate, such as eggs, beef, poultry, fish, salads (except potatoes and other starchy vegetables).
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cancer, Breast Cancer, Colon Cancer, Cervical Cancer, Uterine Cancer, Ovarian Cancer
Keywords
Diet, Cancer, Alternative, Breast, Colon, Cervix, Uterus, Ovary, Metastatic, Nutrition, Carbohydrate
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
10 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Dietary modification
Arm Type
Experimental
Arm Description
Patients are placed on a low carbohydrate diet (<30 grams/day) for 28 days.
Intervention Type
Behavioral
Intervention Name(s)
Very low carbohydrate diet (approximately 20 grams per day)
Intervention Description
Very low carbohydrate diet for a duration of four weeks.
Primary Outcome Measure Information:
Title
Change in tumor FDG uptake from PET/CT imaging over a 28 period. PET is done at baseline and 28 days
Time Frame
28 day trial
Secondary Outcome Measure Information:
Title
Safety of a very low carbohydrate diet in individuals with metastatic cancer
Time Frame
28 days
10. Eligibility
Sex
All
Minimum Age & Unit of Time
21 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
You're an adult with metastatic cancer (breast, colon; others may qualify) that has been resistant to chemotherapy or would like a break from chemotherapy.
Your tumor shows up on a PET or PET/CT scan.
You are willing to closely follow a diet which strictly limits your carbohydrate intake (sugars, starches, etc). We will help you with nutrition counseling but you must prepare your meals, or have someone help you prepare your meals.
You are able to come to the Albert Einstein College of Medicine in Bronx, NY for an initial evaluation appointment and weekly nutrition counseling appointments for a four-week period.
Exclusion Criteria:
Have a heart condition, liver condition or any other disease or condition that makes it difficult or medically hazardous (as determined by your doctor) for you to follow the study diet.
Have kidney or kidney stone disease.
Are too thin or have lost too much weight.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Eugene Fine, MD
Organizational Affiliation
Albert Einstein College of Medicine
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
C.J. Segal-Isaacson, EdD, RD
Organizational Affiliation
Albert Einstein College of Medicine
Official's Role
Study Director
Facility Information:
Facility Name
The Albert Einstein College of Medicine of Yeshiva University
City
Bronx
State/Province
New York
ZIP/Postal Code
10461
Country
United States
12. IPD Sharing Statement
Citations:
PubMed Identifier
19480693
Citation
Fine EJ, Miller A, Quadros EV, Sequeira JM, Feinman RD. Acetoacetate reduces growth and ATP concentration in cancer cell lines which over-express uncoupling protein 2. Cancer Cell Int. 2009 May 29;9:14. doi: 10.1186/1475-2867-9-14.
Results Reference
background
Citation
Fine EJ, Segal-Isaacson CJ, Feinman R, Sparano J: Carbohydrate restriction in patients with advanced cancer: a protocol to assess safety and feasibility with an accompanying hypothesis. Commun Oncol 2008;5:22-26
Results Reference
background
Links:
URL
http://www.einstein.yu.edu/rechargetrial/page.aspx
Description
The RECHARGE Trial at The Albert Einstein College of Medicine
URL
http://www.einstein.yu.edu/home/faculty/profile.asp?id=2013&k=
Description
Faculty Profile Site for Eugene Fine, Principle Investigator
Learn more about this trial
The RECHARGE Low Carbohydrate Diet Trial for Metastatic Cancer
We'll reach out to this number within 24 hrs